Natco Pharma has announced the completion of a regulatory inspection from the United States Food and Drug Administration (USFDA) for its Formulation facility in Ramky SEZ, near Visakhapatnam (Vizag), India, which was conducted from January 30, 2023 to February 3, 2023.

At the end of the inspection, the facility received two observations, one on the written production process control procedure and the other on the investigation procedure. The company is confident of addressing all observations within the stipulated time.